Efficacy, safety and tolerability of aliskiren, a direct renin inhibitor, in women with hypertension: a pooled analysis of eight studies.

Efficacy, safety and tolerability of aliskiren, a direct renin inhibitor, in women with hypertension: a pooled analysis of eight studies.

Item
http://www.wikidata.org/entity/Q43143679
Beta-blockers for hypertensionBeta-blockers for hypertensionBeta-blockers for hypertension.Aliskiren, the first direct renin inhibitor: assessing a role in pediatric hypertension and kidney diseases.Aliskiren - an alternative to angiotensin-converting enzyme inhibitors or angiotensin receptor blockers in the therapy of arterial hypertensionAliskiren vs. other antihypertensive drugs in the treatment of hypertension: a meta-analysis.Blood pressure lowering efficacy of renin inhibitors for primary hypertension.Renin and cardiovascular disease: Worn-out path, or new direction.Aliskiren/amlodipine as a single-pill combination in hypertensive patients: subgroup analysis of elderly patients, with metabolic risk factors or high body mass index.The role of direct renin inhibition in clinical practice: focus on combination therapy.Safety and efficacy of aliskiren in the treatment of hypertension: a systematic overview.An evaluation of the latest evidence relating to renin-angiotensin system inhibitors.An observational, prospective, open-label, multicentre evaluation of aliskiren in treated, uncontrolled patients: a real-life, long-term, follow-up, clinical practice in Italy.Age and sex effects on the single- and multiple-dose safety and pharmacokinetics of the new renin inhibitor ACT-178882.
P2860

Efficacy, safety and tolerability of aliskiren, a direct renin inhibitor, in women with hypertension: a pooled analysis of eight studies.

Item
http://www.wikidata.org/entity/Q43143679
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh-hant
name
Efficacy, safety and tolerabil ...... led analysis of eight studies.
@en
Efficacy, safety and tolerabil ...... led analysis of eight studies.
@nl
type
label
Efficacy, safety and tolerabil ...... led analysis of eight studies.
@en
Efficacy, safety and tolerabil ...... led analysis of eight studies.
@nl
prefLabel
Efficacy, safety and tolerabil ...... led analysis of eight studies.
@en
Efficacy, safety and tolerabil ...... led analysis of eight studies.
@nl
P1433
P1476
P2093
P2860
P2888
P304
P31
P356
P433
P478
P577
P6179
P698
P356
P1433
P1476
Efficacy, safety and tolerabil ...... led analysis of eight studies.
@en
P2093
P2860
P2888
P304
P31
P356
P433
P478
P577
P6179
P698